NLS PHARMACEUTICS LTD
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for NLS PHARMACEUTICS LTD *W EXP 02/02/202, CUSIP H57830111.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for NLS PHARMACEUTICS LTD *W EXP 02/02/202, CUSIP H57830111.